Literature DB >> 2219876

Recent developments in radial keratotomy.

G O Waring, J T Carter.   

Abstract

The Scientific Board of the California Medical Association presents the following inventory of items of progress in ophthalmology. Each item, in the judgment of a panel of knowledgeable physicians, has recently become reasonably firmly established, both as to scientific fact and important clinical significance. The items are presented in simple epitome and an authoritative reference, both to the item itself and to the subject as a whole, is generally given for those who may be unfamiliar with a particular item. The purpose is to assist busy practitioners, students, research workers, or scholars to stay abreast of these items of progress in ophthalmology that have recently achieved a substantial degree of authoritative acceptance, whether in their own field of special interest or another. The items of progress listed below were selected by the Advisory Panel to the Section on Ophthalmology of the California Medical Association, and the summaries were prepared under its direction.

Mesh:

Year:  1990        PMID: 2219876      PMCID: PMC1002506     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  4 in total

1.  Development of a system for excimer laser corneal surgery.

Authors:  G O Waring
Journal:  Trans Am Ophthalmol Soc       Date:  1989

2.  Further studies of four incision radial keratotomy.

Authors:  A V Spigelman; P A Williams; R L Lindstrom
Journal:  Refract Corneal Surg       Date:  1989 Sep-Oct

3.  Topographic analysis and visual acuity after radial keratotomy.

Authors:  P J McDonnell; J Garbus; P F Lopez
Journal:  Am J Ophthalmol       Date:  1988-12-15       Impact factor: 5.258

4.  Results of the Prospective Evaluation of Radial Keratotomy (PERK) Study 4 years after surgery for myopia. Perk Study Group.

Authors:  G O Waring; M J Lynn; B Fielding; P A Asbell; H D Balyeat; E A Cohen; W Culbertson; D J Doughman; P Fecko; M B McDonald
Journal:  JAMA       Date:  1990-02-23       Impact factor: 56.272

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.